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Diversification of form and function during evolution is driven by 
changes in cis-regulatory sequences in numerous cases1. Natural selec-
tion acts on preexisting genetic variation in promoter and enhancer 
regions, thereby rewiring transcriptional networks during speciation. 
Recent studies have indeed documented substantial variation in regula-
tory sequences in natural populations of flies compared with humans2,3. 
However, under normal conditions, only little gene-expression varia-
tion and minor phenotypic differences are present within a population. 
Developmental programs are thought to be ‘buffered’ or ‘canalized’ 
to produce very similar phenotypes despite genetic variation4. One 
possible molecular example of such buffering ability involves the 
chaperone HSP90, which stabilizes key proteins in signaling pathways 
and transcriptional networks. HSP90 is thought to facilitate the 
accumulation of genetic variation in a population without having large 
consequences on an individual’s reproductive fitness. Decreased HSP90 
function leads to phenotypic manifestation of cryptic genetic variation 
in budding yeast, Drosophila, Arabidopsis and natural populations of 
fish5–8. Thus, HSP90 has been proposed to function as an evolutionary 
capacitor allowing natural populations to accumulate genetic variation, 
and this genetic variation is potentially released as phenotypic variation 
under stressful conditions that compromise HSP90 function9.
Despite the broad ramifications of the buffering ability of HSP90, 
surprisingly little is known about the molecular basis of this function. 
HSP90-buffered traits in yeast have been mapped to protein-coding 
as well as cis-regulatory regions of the genome5. Although protein 
variants can be buffered by HSP90 via their stabilization, it is not clear 
how the chaperone minimizes the transcriptional effects of regulatory 
variation in promoter and enhancer sequences. Recent work has shown 
that HSP90 binds chromatin at gene regulatory elements in flies and 
mammals and stabilizes transcriptional and epigenetic factors, thus 
possibly explaining the buffering of regulatory variation10–13. Advances 
in population genomics and large-scale efforts to functionally anno-
tate promoters and enhancers have provided a framework in which to 
investigate HSP90-mediated buffering of cis-regulatory variation.
Natural insertions of transposable elements (TEs) in regulatory 
regions present a rich source of variation within a population. Indeed 
genome sequencing of 18 distinct mouse strains has uncovered abun-
dant variation in TE insertions across the genome14. TEs are transcrip-
tionally repressed by epigenetic mechanisms including trimethylation 
of histone H3 at Lys9 (forming H3K9me3) and DNA methylation15. 
TEs in the germline are additionally silenced by post-transcriptional 
piwi-interacting RNA (piRNA) mechanisms that depend on HSP90 
(refs. 16–18). In Drosophila, depletion of HSP90 function in germ 
cells causes transposition of TEs to new genomic positions, thereby 
possibly disrupting critical genes19. Rather than buffering preexisting 
genetic variation, the germline-specific function of HSP90 controls 
de novo variation, thus leading to heritable phenotypic diversity19.
In somatic cells, even without transposition, TEs influence the 
expression of nearby genes and consequently organismal phenotypes, 
as exemplified by a TE insertion near the agouti locus in mice20. The 
gene-regulatory potential of TEs has also fueled evolutionary diversi-
fication and innovation in craniofacial development and mammalian 
pregnancy21–23. It is unclear how randomly integrated TEs initially 
appearing as genetic variations within a population ultimately regulate 
the expression of critical genes and thus developmental trajectories. 
We sought to determine whether the evolutionary capacitor HSP90 
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might facilitate fixation of mouse TEs in a population by first buffer-
ing the consequences of new TE insertions in the few individuals that 
carry these variations.
RESULTS
If HSP90 buffers genetic variation caused by TE insertions in gene-
regulatory regions and thus acts as an evolutionary capacitor, two 
testable predictions can be made. First, HSP90 would control TE 
expression and its effect on nearby host genes in somatic cells, thereby 
mitigating the developmental and phenotypic effects associated 
with TE insertions. Second, individuals in natural populations would 
accumulate genetic variation caused by TEs without exhibiting any 
overt differences in gene-expression profiles, as long as HSP90 is 
functional. In the present study, we tested these predictions by using 
gene-expression signature as a quantitative phenotype contingent on 
TE-induced genetic variation.
HSP90	and	the	repression	of	ERVs	in	somatic	cells
To test whether HSP90 regulates the transcription of TEs in somatic 
cells, we selected three distinct cell types from mice representing 
different developmental stages and lineages: pluripotent embryonic 
stem cells (ESCs), multipotent neuronal progenitor cells (NPCs) 
and bone-marrow-derived macrophages as primary differentiated 
cells. The cells were treated with nanomolar concentrations of NVP-
AUY922, a specific and potent small-molecule inhibitor of HSP90 
(Online Methods and ref. 24). Use of this pharmacological inhibi-
tion rather than genetic or RNA-interference-mediated depletion of 
HSP90 protein allowed us to expose cells to mild modulation of the 
chaperone activity over a short term, thereby avoiding effects on cell 
viability and compensatory expression of the two HSP90 isoforms 
(Supplementary Table 1 and Supplementary Fig. 1a). NVP-AUY922 
is currently being used in clinical trials as an anticancer therapeutic 
and has been proven to be a highly specific HSP90 inhibitor25.
The global changes in the transcriptomes of all three cell types 
as a result of HSP90 inhibition were assessed by RNA sequencing 
(RNA-seq) in triplicate. To determine whether HSP90 inhibition 
affects the transcriptional activity of TEs, we mapped the RNA-seq 
reads to the mouse genome. Unexpectedly, a fraction of TEs were 
significantly up- or downregulated after HSP90 inhibition (Fig. 1a–e, 
Supplementary Fig. 1b–g and Supplementary Table 2). Of the approxi-
mately 1,400 types of repetitive elements analyzed, 175, 88 and 144 types 
were upregulated in ESCs, NPCs and macrophages, respectively (with 
a fold change greater than two and an adjusted P value <0.01, on the 
basis of DESeq2 analysis of three independent cell cultures, as outlined 
in Online Methods; Supplementary Fig. 1g). Genome-browser views 
of normalized data from RNA-seq confirmed the analysis (Fig. 1d,e 
and Supplementary Fig. 1b–f). TEs such as intracisternal A parti-
cle type Ez (IAPEz) were upregulated in all three cell types, whereas 
other subtypes exemplified by mouse ERV type L (MERV-L) were 
affected in a cell-type-specific manner (Supplementary Table 2). 
We validated our observations by using an independent method 
of reverse transcription followed by quantitative PCR (RT–qPCR; 
Fig. 1f). In addition, we observed the increases in IAPEz and MERV-
L at two lower concentrations of HSP90 inhibitor without inducing 
a heat-shock response (Supplementary Fig. 1h). The robust changes 
in the repertoire of TE expression supported the possibility that 
HSP90 regulates TEs in the examined cell types representing various 
developmental lineages.
Mammalian TEs can be classified into two broad groups—DNA 
transposons and retrotransposons—depending on the requirement of 
an RNA intermediate for the transposition reaction. Retrotransposons 
can be further subdivided into long or short interspersed nuclear 
elements (LINEs and SINEs, respectively) and long terminal repeat 
(LTR) transposons26. The sequences within the LTR transposons can 
be traced back to mammalian retroviruses that probably resulted from 
primary infection of viruses in the germline27. The LTR transposons 
are thus termed ERVs. The various classes of TEs are silenced through 
distinct epigenetic pathways. Hence, misregulation of any particular 
type of TEs would reflect compromised specific molecular mecha-
nisms. An overwhelming majority of TEs misregulated after HSP90 
inhibition in all three cell types belonged to the class of ERVs (Fig. 1g 
and Supplementary Table 2), thus implicating HSP90 in specific 
pathways regulating TEs in the mouse genome. In this study, to 
dissect the capacitor function of HSP90, we focused on ERVs that 
were upregulated after HSP90 inhibition.
Genes	neighboring	ERVs	are	upregulated	by	HSP90	inhibition
Only a small number of mammalian ERVs are intact and capable 
of transposing to a new location28. Even if they integrate at ectopic 
sites in the genome after HSP90 inhibition, such de novo variation 
in somatic cells is not heritable and hence is of little evolutionary 
consequence. Transcriptionally activated ERVs may instead influ-
ence regulation of host genes in the vicinity of preexisting insertion 
sites and consequently affect phenotypes after HSP90 inhibition. 
We tested whether the capacitor function of HSP90 buffers or 
minimizes regulatory effects of ERVs on host genes within 200 kb 
of the ERV insertions annotated in the mouse genome. Indeed, host 
genes located within 25 kb up- or downstream of preexisting ERV-
insertion sites were upregulated in cells with compromised HSP90 
activity (Fig. 2a, Supplementary Fig. 2a and Supplementary Table 3). 
Importantly, the effect on the neighboring genes was restricted to 
ERVs targeted by HSP90 for silencing: MERV-L and IAPEz in ESCs 
(Fig. 2a) and IAPEz in NPCs (Supplementary Fig. 2a). A closely 
related ERV, origin-region repeat 1 type D2 (ORR1D2), which was 
not misregulated after HSP90 inhibition, did not show any consistent 
effect on genes in its vicinity. Thus, under normal conditions, the 
chaperone activity of HSP90 minimizes the regulatory influence of 
ERVs on neighboring genes.
To dissect the neighborhood effect further, we focused on genes 
that were immediate neighbors of the ERVs not farther than 25 kb 
away, because the effect on gene expression was consistent only 
within this range (Fig. 2a). On average, genes next to IAPEz, as com-
pared with all expressed genes in the genome, showed an increase 
in expression after HSP90 inhibition, irrespective of the cell type 
examined (Fig. 2b and Supplementary Fig. 2b). In agreement with 
MERV-L being induced by HSP90 inhibition only in ESCs, imme-
diate neighboring genes of MERV-L were upregulated in ESCs, but 
there were no significant changes in their expression in NPCs 
and macrophages (Fig. 2c). As expected, adjacent genes located 
beyond 25 kb from their closest ERV, as compared with adjacent 
genes within 25 kb, showed a decreased effect after HSP90 inhibition 
(Supplementary Fig. 2b–f).
ERVs are known to regulate nearby genes in some cases by form-
ing a chimeric transcript originating from the LTR region and con-
tinuing through the adjacent gene. Using the paired-end RNA-seq 
data, we found that HSP90 inhibition increased chimeric transcrip-
tion of several genes close to MERV-L and IAPEz, but not ORR1D2 
(Supplementary Table 4). We independently confirmed the enhanced 
chimeric transcription of three genes after HSP90 inhibition by 
using PCR and gel electrophoresis as well as RT–qPCR (Fig. 2d and 
Supplementary Fig. 2g–k). The cell-type-specific neighborhood effect 
and chimeric transcription induced by HSP90 inhibition suggested 
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that ERV upregulation is causally associated with increased expres-
sion of neighboring genes rather than being a direct effect of HSP90 
inhibition on genes themselves. Thus, transcription of mouse genes 
appears to become responsive to HSP90 inhibition depending on the 
genes’ proximity to ERVs.
HSP90	cooperates	with	TRIM28	(KAP1)	in	restricting		
gene	expression
ERV-adjacent genes that became ectopically activated after HSP90 
inhibition typically showed a highly restricted expression pattern 
across mouse tissues (Fig. 3a and Supplementary Fig. 3a,b). Many 
of the ectopically expressed genes perform essential tasks in develop-
ment and physiology (Fig. 3b and Supplementary Fig. 3c,d), thus 
emphasizing the potential phenotypic effects of their misregula-
tion. HSP90 probably keeps the ability of ERVs to rewire the host 
transcriptional network in check by repressing the ERVs, thereby 
maintaining phenotypic robustness. Compromise in the chaperone 
activity of HSP90 is thus likely to alter the developmental trajectory 
or physiological function of differentiated cells.
It is unclear how HSP90 regulates the expression of ERVs, thereby 
restricting tissue-specific gene expression. As a molecular chaperone, 
HSP90 might stabilize clients, such as transcription factors and 
chromatin regulators, that are involved in the epigenetic repression 
of ERVs. Deletion or knockdown of such a client protein would be 
expected to cause an ERV upregulation similar to that seen in HSP90 
inhibition. We used published RNA-seq data sets from ESCs with 
depletion of proteins required for TE repression, such as histone 
deacetylases; histone methyltransferases (G9a, SET-domain bifur-
cated 1 (SETDB1) and suppressor of variegation 3-9h (SUV39h)); 
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Figure 1 HSP90 inhibition causes misregulation of TEs in different mouse cell types. (a–c) Changes in expression of all annotated TEs after HSP90 
inhibition in ESCs (a), NPCs (b) and macrophages (c), plotted against the mean expression levels under control conditions. Data obtained by RNA-seq 
analysis are shown as means from 3 independent cell cultures. TEs with significant misregulation are highlighted in red (adjusted P value <0.01, on the 
basis of DESeq2 analysis of three independent cell cultures, as outlined in Online Methods). The list of all misregulated TEs with corresponding fold 
changes is available in Supplementary Table 2. (d,e) Genome-browser snapshot of genomic loci with indicated ERVs. RNA-seq read counts in control 
and HSP90 inhibition (HSP90i) conditions are plotted on the y axis. Genomic coordinates (mouse genome build mm10) are as follows: chromosome 7, 
137894161–137901058 (d) and chromosome 10, 59381391–59388056 (e). (f) RT–qPCR analyses of a selected set of differentially expressed ERVs 
in the indicated cell types. Fold change is shown as mean and s.e.m. from two independent cell cultures. (g) The proportion of different TE subtypes  
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motif-containing 28 (TRIM28, hereafter referred to as KAP1 for 
Krüppel-associated box–associated protein 1))29–37. Hierarchical 
clustering of data sets on the basis of changes in expression of ERVs 
resulted in a tree grouping HSP90 together with KAP1 and SETDB1 
(Fig. 3c). The KAP1 co-repressor recruits the H3K9 methyltransferase 
SETDB1 to ERVs38, and the clustering of SETDB1 and KAP1 together 
with HSP90 implicates the chaperone in this epigenetic-repression 
pathway. Various independent lines of evidence further confirmed that 
KAP1 and HSP90 cooperatively repress ERVs. First, genes upregulated 
in Kap1 (official symbol Trim28)- and Setdb1-knockout cells signifi-
cantly overlapped with those in HSP90-inhibited ESCs (Fig. 3d and 
Supplementary Table 3). A detailed analysis of the extent of overlap 
revealed a much larger set of genes co-regulated by HSP90 and KAP1 
as compared with HSP90 and SETDB1 (Supplementary Fig. 4a). This 
observation raises the possibility that HSP90 may chaperone KAP1 not 
only in the context of SETDB1 but also in KAP1 complexes with other 
chromatin regulators or transcription factors25. Second, genes neigh-
boring MERV-L and IAPEz were upregulated after Kap1 knockout in 
a manner quantitatively similar to that observed after HSP90 inhibi-
tion (comparison of Fig. 2a with Supplementary Fig. 4b). Individual 
ERV-gene pairs known to be regulated by KAP1-dependent H3K9me3 
were also upregulated after HSP90 inhibition (Supplementary Fig. 5). 
In agreement with previously reported results30, Setdb1 knockout 
showed an effect only on genes neighboring IAPEz, but not MERV-L 
(Supplementary Fig. 4c). In the case of both Setdb1- and Kap1-
knockout cells, genes close to ORR1D2 were not affected, similarly 
to the effects in HSP90 inhibited ESCs. Third, we identified chimeric 
transcripts that were induced to a similar extent under both HSP90-
inhibition and Kap1-knockout conditions, as exemplified by Rimklb, 
starting from an MT2B2 LTR region (Supplementary Fig. 4d and 
Supplementary Table 4). Fourth, HSP90 and KAP1 interacted with 
each other, as shown by reciprocal immunoprecipitations (Fig. 3e,f). 
These data from mouse ESCs corroborate independently reported 
interactions between HSP90 and KAP1 in the human cancer cell 
line K562, identified in an unbiased manner39. Finally upregulation 
of MERV-L and IAPEz after HSP90 inhibition requires functional 
KAP1, because KAP1-deficient ESCs40 showed an attenuated increase 
in ERVs in response to HSP90 inhibition (Fig. 3g).
How might HSP90 regulate ERVs via the KAP1 pathway? KAP1 sta-
bility does not depend on HSP90 function (Fig. 3h, inset), as might be 
suspected from the direct chaperoning of KAP1 by HSP90. Nonetheless, 
HSP90 colocalized with KAP1 at the tested ERVs (Supplementary 
Fig. 6a), and KAP1 binding to chromatin required HSP90 activity 
(Fig. 3h and Supplementary Fig. 6b). Given that the repressive 
H3K9me3 mark at IAPEz was dependent on KAP1 (Supplementary 
Fig. 6c,d), we analyzed whether this chromatin modification was also 
affected after HSP90 inhibition. The loss of chromatin-bound KAP1 
at IAPEz after HSP90 inhibition was accompanied by a decrease in 
H3K9me3 at this region (Fig. 3h and Supplementary Fig. 6b), thus 
confirming that KAP1-mediated recruitment of repressive machinery 
to ERVs requires HSP90 activity. The depletion of this repressive his-
tone modification in HSP90 inhibitor-treated ESCs was not a result of 
a global effect, because Suvar39h-dependent H3K9 trimethylation31 
at major satellites was not significantly affected by the treatment (Fig. 
3h). Thus, through a combination of computational, biochemical and 
genetic approaches, our data support a model in which HSP90 and 
KAP1 cooperatively mediate ERV repression in ESCs.
HSP90	buffers	strain	variations	due	to	ERV	insertions
ERVs have the potential to affect the expression of genes located near 





















































































































P = 5.75 × 10–11 P = 0.019 P = 0.00098
P = 1.03 × 10–13 P = 0.1118 P = 0.061











Expected genomic distance ~18,514 bp
expected size of the chimeric RNA ~1,150 bp
Expected genomic distance ~5,394 bp










































Figure 2 HSP90 inhibition affects expression of genes in the vicinity of 
ERVs. (a) HSP90-inhibition-induced changes in the expression of genes 
located within a 200-kb region around ERV insertions in ESCs. The 
analyzed subtypes of ERVs are shown in different colors. (b,c) HSP90-
inhibition-induced changes in expression of all transcribed genes in the 
genome (black boxes), in comparison with expressed genes adjacent to 
IAPEz (blue boxes in b) and MERV-L (red boxes in c). Only adjacent genes 
within 25 kb from the ERV were considered. Box plots display the 25th 
to 75th percentiles (boxes), medians (lines) and 1.5× the interquartile 
range (whiskers). Outliers are depicted as individual dots. P values 
calculated by two-sided Wilcoxon rank-sum test (based on RNA-seq of 
three independent cell cultures) are shown below each comparison and 
denote the significance of the difference between the corresponding sets 
of genes. (d) Top left, schematic showing the chimeric transcript starting 
from the MT2B1 LTR region and continuing to the neighboring gene Ei24. 
Top right, agarose gel showing an RT–PCR product of 1,150 bp, expected 
only in the presence of transcriptional fusion and splicing, in samples 
treated with HSP90 inhibitor. Bottom, RT–qPCR analyses using the 
indicated primer pair (schematics at left) showed a large increase in the 
amount of chimeric transcript after Hsp90 inhibition (bar graph at right, 
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individuals, owing to random ancestral transposition events, distinct 
sets of genes are likely to exhibit ERV-mediated misregulation in 
different individuals. By repressing ERVs with the help of KAP1, HSP90 
may minimize the transcriptional consequences of ERV insertions 
and hence buffer the corresponding genetic variation in a population. 
We tested this important tenet of the buffering hypothesis in two models 
of genetic variation by using either synthetically altered ERV-insertion 
sites or naturally available polymorphisms in the mouse genome.
To experimentally modify the existent ERV insertions, we focused 


























































































































P = 1.2 × 10–121
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Figure 3 HSP90 represses cell-type-specific genes and ERVs through the KAP1–SETDB1 pathway. (a) Heat map showing the expression of selected 
genes across indicated mouse tissues or cell types. Genes adjacent to ERVs that are ectopically expressed in ESCs after HSP90 inhibition were selected 
for this analysis. The heat map was generated with RNA-seq data from ENCODE. (b) Genes in a, clustered on the basis of common gene-ontology terms, 
as indicated. (c) Hierarchical clustering of RNA-seq data on the basis of fold changes in ERV expression after HSP90 inhibition (reported here) and 
depletion of the specified chromatin regulators (data from published sources; details in Online Methods). KO, knockout; DKO, double knockout; TKO, 
triple knockout; KD, knockdown. (d) Venn diagrams depicting the overlap of genes upregulated in ESCs with knockout of either Kap1 (top) or Setdb1 
(bottom), as compared with genes upregulated after HSP90 inhibition. P values were calculated with a hypergeometric test and show the significance of 
the overlap. (e) Western blots showing the presence of HSP90 and KAP1 proteins in complexes enriched by using immobilized HSP90 inhibitor (HSP90i) 
or an inactive drug (control). (f) Western blots showing the presence of HSP90 and KAP1 proteins in complexes enriched by using antibody against 
KAP1. IP, immunoprecipitation. (g) RT–qPCR analyses showing the effect of HSP90 inhibition on the expression of the indicated ERVs, in Kap1 wild-type 
ESCs (−tamoxifen) and Kap1-knockout ESCs (+tamoxifen). Fold changes are shown as mean ± s.e.m. from three independent cell cultures. Inset, KAP1 
immunoblot demonstrating Kap1 knockout induced by tamoxifen treatment of floxed Kap1 cells. (h) Chromatin IP–qPCR for KAP1 and H3K9me3 in ESCs 
treated with or without HSP90 inhibitor. Enrichment relative to control conditions is shown as mean ± s.e.m. of three independent cell cultures. Red dotted 











































nature structural & molecular biology	 VOLUME 24 NUMBER 3 MARCH 2017 239
a r t i c l e s
Mother: 129S1 Father: CASTEiJ
Allele-specific transcriptome analysis
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Figure 4 Genetic variation caused by preexisting ERV insertions is buffered by HSP90. (a) Top, schematic of genotyping primers and guide RNAs (gRNAs) 
used for the design and validation of CRISPR–Cas9-mediated deletion of IAPLTR2 upstream of the C1s1 gene. Bottom left, agarose gel genotyping two 
independent clones to confirm deletion of IAPLTR2. Bottom right, bar graph showing the effect of HSP90 inhibition on expression of IAPEz and C1s1, as 
determined by RT–qPCR in both clones; data are shown as mean ± s.e.m. from 3 independent cell cultures for each clone. (b) Experimental design to study 
the effect of HSP90 inhibition on allele-specific expression of genes. (c) Allele-specific changes in expression after HSP90 inhibition. Alleles neighboring 
either MERV-L or IAPEz insertion are plotted on the x axis. Alleles without either MERV-L or IAPEz insertion in proximity are plotted on the y axis. Black 
circles, expression changes in ESCs; green triangles, expression changes in NPCs. (d) HSP90-inhibition-induced changes in the expression of alleles from 
the two parental strains, grouped according to the presence or absence of nearby MERV-L or IAPEz in ESCs (black) and NPCs (green). The y axis shows 
average expression (mean ± s.e.m.) of seven genes for ESC and 16 genes in NPC. (e,f) Genome-browser profiles of unprocessed RNA-seq reads at the Arsk 
locus in ESCs (e) and at the Col22a1 locus in NPCs (f). Only reads that mapped to one of the two alleles are plotted. At the Arsk locus, MERV-L is inserted 
in the CASTEiJ strain, whereas at the Col22a1 locus IAPLTR1a is inserted in the 129S1 strain, as shown. The strain-specific effects of HSP90 inhibition on 
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of the gene C1s1 in the genome (a region referred to as C1s1.
IAPLTR2). This LTR region showed KAP1 and an H3K9me3 signal 
that decreased after HSP90 inhibition (Fig. 3h), with a concomitant 
increase in expression of C1s1 (Supplementary Table 3). We used 
the CRISPR–Cas9 system to delete C1s1.IAPLTR2, thus generating 
two independent clones isogenic with parental ESCs but lacking this 
particular instance of the ERV (Fig. 4a). After HSP90 inhibition, 
the two deletion clones showed an upregulation of IAPEz (from all 
instances of IAPEz insertions across the genome) comparable to that 
in the isogenic parental ESC, but did not activate C1s1 expression 
(Fig. 4a). The removal of ERV from the neighborhood made the C1s1 
gene nonresponsive to HSP90 inhibition, thus strongly supporting 
the notion that insertion of ERVs makes nearby genes responsive to 
HSP90 inhibition.
We further tested the buffering ability of HSP90 by leveraging 
natural genetic variation in ERV-insertion sites. Comprehensive 
sequencing and annotation of whole genomes of several mouse strains 
allowed us to identify genes with strain-specific ERV insertions in the 
neighborhood (ref. 14 and Supplementary Fig. 6e). ESCs derived 
from 129S1 and CASTEiJ backgrounds carrying ERV insertions 
close to five genes were compared with ESCs derived from a C57BL6 
background that did not have ERV insertions near these five genes. 
After HSP90 inhibition, all five genes were upregulated in 129S1-
CASTEiJ ESCs but not in C57BL6 ESCs (Supplementary Fig. 6e), 
thus suggesting that natural variation in ERV-insertion sites may play 
an important role in responsiveness to HSP90 inhibition.
ESCs from two different genetic backgrounds exhibited differences 
in genomes beyond these five genes, thus providing a potential theo-
retical explanation for the differential responsiveness to HSP90 inhibi-
tion. To further refine this experiment with natural genetic variation, 
we used cells from F1 heterozygous offspring of two inbred strains, 
129S1 and CASTEiJ. The maternal and paternal alleles, representing 
two individual mouse strains, shared an identical set of trans-acting 
factors in the cells of the F1 offspring (Fig. 4b). We investigated the 
correlation between strain-specific ERV insertions and changes in 
expression of the nearest gene after HSP90 inhibition. Allele-specific 
RNA-seq analysis in ESCs and NPCs derived from F1 heterozygotes 
confirmed that the allele with a nearby ERV, compared with the other 
allele of the same gene without any ERV, was significantly upregulated 
after HSP90 inhibition (Fig. 4c–f). For example, the Arsk gene from the 
CASTEiJ strain has an intronic MERV-L and was upregulated three-
fold after HSP90 inhibition (Fig. 4e). In comparison, the Arsk gene 
from the 129S1 strain has no ERV insertions nearby and showed little 
transcriptional change when HSP90 activity was decreased. Thus our 
genome-wide data based on natural genetic variation as well as 
targeted synthetic variation of one ERV instance confirm that the 
location of ERV insertions plays a crucial role in determining the 
transcriptional response of mouse genes to HSP90 inhibition.
Stress	decreases	the	repressive	effect	of	HSP90	on	ERV
HSP90 function is compromised under various natural stresses, such as 
alterations in temperature, pH, salinity and toxicity of food41. To dem-
onstrate that HSP90 inhibition mimics the effect of environmental fac-
tors, we exposed cells to stresses mimicking natural conditions such as 
fever temperatures, heavy-metal arsenic treatment and oxidative stress. 
All three stresses led to an upregulation of both MERV-L and IAPEz 
elements in ESCs, as shown by RT–qPCR (Supplementary Fig. 6f). 
Host genes near ERV-insertion sites are hence likely to respond to 
environmental stress similarly to their response to HSP90 inhibition.
In summary, the data presented here support a model in which 
HSP90 silences the transcriptional influence of ERVs on neighboring 
genes, in cooperation with KAP1. Genes near ERV-insertion sites in 
the sequenced mouse genomes encode proteins driving morphogen-
esis (Fig. 3a,b), thus making developmental trajectories responsive 
to stress in an HSP90-contingent manner. However, given the poly-
morphisms in ERV insertions within a population42, distinct genes 
respond to the same stress in different individuals (Fig. 5). Thus, the 
differential transcriptional response of these genes after stress among 
members of a population is likely to lead to phenotypic variation, as 
shown in numerous studies5–9,43. In conclusion, our study indicates 
another mechanism by which HSP90 acts globally to buffer genetic 



































































Figure 5 The role of HSP90 and stress in genotype–phenotype mapping through buffering gene-expression variation caused by ERVs. A model showing 
three genetic variants (A, B and C) with different locations of ERV in their genomes (denoted by two genes). The HSP90–KAP1 complex buffers the 
regulatory effects of ERV on host genes, thus resulting in similar gene-expression patterns and phenotypes among the three variants. Stress conditions 
cause a compromise in the buffering ability of HSP90, thus activating the target ERVs and nearby host genes, which are distinct in each individual.  
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DISCUSSION
By defining ERVs as one of the sources of HSP90-buffered genetic vari-
ation, our work paves the way for confirming important predictions of 
the evolutionary capacitor hypothesis. Linking of HSP90 with the epi-
genetic-repression machinery consequently connects the transcription 
of ERV to nearby genes after environmental stresses. The enormous 
number of ERV insertions in the mouse genome15 suggests the 
possibility of an accumulation of genetic variation buffered by the 
capacitor HSP90. Most importantly, ERVs have driven transcrip-
tional networks underlying major evolutionary innovations such as 
innate immune responses44. By allowing nearby genes to respond to 
pathogenic stimuli, ERVs have played an important role in the evolu-
tion of host defense and the expansion of ecological niches. HSP90 
may have helped ERVs accumulate during evolutionary periods near 
genes, thus eventually making them responsive to external stimuli. 
By chaperoning transcriptional regulators, HSP90 has expanded its 
repertoire of buffered genetic variation from protein-coding regions 
to gene-regulatory noncoding elements.
Earlier studies in flies and mice have indicated the role of HSP90 
in controlling transposition of TEs in the germline via piRNA path-
ways18,45. HSP90 mutants thus have a mutator phenotype, because 
transposition in the germline introduces new heritable genetic vari-
ation. Our studies support an additional, and perhaps unrelated, 
mechanism by which HSP90 shapes the role of TEs in evolution. 
First, the upregulation of genes neighboring ERVs, as reported here, 
is unlikely to be due to new transposition events, because we assessed 
only preexisting ERV locations annotated in the sequenced genomes. 
Second, HSP90-mutant germ cells exhibit a derepression of the LINE 
L1 element45, which was transcriptionally unaffected in our experi-
ments performed on somatic cells (Supplementary Table 2). Third, 
the transcriptional changes after HSP90 inhibition reported in this 
study were inferred from a population of cells, thus nullifying the 
effects of random transposition occurring in a minority of cells, if 
at all. Fourth, piRNA-based repression mechanisms have not been 
reported to operate in any of the cell types examined in this study. 
Moreover, recent reports have uncoupled the piRNA-dependent phe-
notypic effects of HSP90 mutations from transposition46. It appears 
that, in addition to repressing transpositions, HSP90 plays a criti-
cal role in neutralizing the transcriptional effects of preexisting TEs. 
Coordination of mutator and capacitor activities within the same 
chaperone system directed toward TEs makes HSP90 a more efficient 
facilitator of diversification than has previously been thought.
HSP90 is a specialized chaperone that also aids in the assembly of 
several multiprotein complexes. At the molecular level, HSP90 may 
facilitate the formation of the KAP1–SETDB1 co-repressor complex, 
either in the nucleoplasm or at chromatin. Alternatively, HSP90 may 
be required for the enzymatic activity of SETDB1 histone methyl-
transferase, which is required to repress ERVs. Given that HSP90 inhi-
bition affects a smaller subset of KAP1- and SETDB1-regulated TEs 
in ESCs, it is more likely that HSP90 is needed for stabilization of a 
few transcription factors that recruit KAP1–SETDB1 to specific ERVs. 
Krüppel-associated-box zinc-finger proteins are known for their role 
in bringing the KAP1 co-repressor to chromatin47, and some zinc-
finger proteins have been found to interact with HSP90 in previous 
unbiased screens48. Additional transcription factors and chromatin 
regulators known to interact with HSP90 may also be involved25. 
A directed biochemical approach would be able to answer the specific 
molecular questions raised by our work.
Critical to the role of HSP90 as a buffer of regulatory variation 
described here is the rewiring of the transcriptional network by dere-
pressed ERVs. Ectopic activation of tissue-specific genes with ontogenetic 
functions (Fig. 3a,b and Supplementary Fig. 3) may underlie 
the acquisition of new developmental or physiological functions. 
Reutilization of ancient genes in new tissue contexts is a recurrent 
evolutionary theme in the generation of new forms and functions1. 
For example, TE-driven placental expression of immune genes is 
thought to be important for maternal-fetal immunotolerance during 
the evolution of pregnancy22. Acquisition of new expression domains 
by key developmental genes may indeed be facilitated by the capacitor 
function of HSP90 via the KAP1–ERV axis described here. Thus, our 
studies provide a molecular framework in which to study HSP90’s 
buffering function directed toward noncoding regulatory variation.
METHODS
Methods, including statements of data availability and any associated 
accession codes and references, are available in the online version of 
the paper.
Note: Any Supplementary Information and Source Data files are available in the online 
version of the paper.
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ONLINE	METHODS
Cell culture, inhibitor treatment, RNA extraction and processing. ESCs 
(obtained from E Heard) were grown in 2i (two-inhibitor) medium with standard 
protocols for maintenance and passaging. NPCs (obtained from A. Akhtar) were 
cultured as described previously49. Macrophages were derived from bone marrow 
of 4-month-old female mice with a BALBc/C57BL6 background (a kind gift from 
T. Lämmermann) by using recombinant murine macrophage colony stimulat-
ing factor (M-CSF; PeproTech, cat. no. 315-02) according to standard protocols. 
Animal experiments were done in accordance with German animal protection 
law (paragraph 4, section 3). Genotypes of cells in culture were confirmed by ana-
lyzing RNA-seq data. Cells were tested for mycoplasma contamination with PCR. 
ESCs and NPCs shared the same genetic background because they were derived 
from an offspring of the cross between a 129S1 female and a CASTEiJ male.
The HSP90 inhibitor NVP-AUY922 was purchased from LC Laboratories. The 
optimal concentration of NVP-AUY922 was empirically determined for each 
cell line used, such that no effect on cell viability was observed after 24 h. HSP90 
inhibition experiments on macrophages were performed between the seventh and 
eighth days after cells were collected from mouse bone marrow. HSP90 inhibi-
tion was carried out with the following concentrations of NVP-AUY922 for 16 h 
with the corresponding cell types: 100 nM for ESCs, 500 nM for macrophages 
and 50 nM for NPCs. We confirmed a lack of cytotoxicity in the RNA-seq data 
(Supplementary Table 1). In addition, we performed experiments in ESCs with 
50 nM and 75 nM NVP-AUY922 for 16 h to expose cells to nonproteotoxic 
conditions (shown in Supplementary Figs. 1h and 6e). To mimic natural stress-
ful conditions, we exposed ESCs to fever temperatures (39.5 °C), As2O3 (final 
concentration 100 nM) and H2O2 (final concentration 5 µM) for 16 h.
After treatment, cells were resuspended in peqGOLD Trifast (VWR 
International, cat. no. 30-2010), and RNA was extracted according to the 
manufacturer’s protocol. DNase I treatment was carried out for 2 h to eliminate 
genomic DNA contamination, by using a TURBO DNase kit (Thermo Fisher 
Scientific, cat. no. AM1907). RNA was analyzed either with RT–qPCR or paired-
end poly(A) RNA sequencing with an Illumina HiSeq system.
For RT–qPCR, reverse transcription was performed with random primers and 
a first-strand cDNA synthesis kit (Thermo Fisher, cat. no. K1612). Absolute SYBR 
Green Rox mix (Thermo Scientific, cat. no. AB1163) was used for qPCR, which 
was carried out on an Applied Biosystems StepOne Plus instrument. Data were 
quantified with the ∆∆Ct method and were normalized to GAPDH expression. 
For agarose gel analysis, cDNA input was normalized before PCR amplification, 
and products were run on a 2% agarose gel.
RNA-seq data were analyzed for the occurrence of chimeric transcripts, 
as described in ref. 31. Three chimeric transcripts were evaluated by qPCR 
and PCR with primers spanning the junction site of the ERV LTR region 
and the adjacent gene. Primers were designed with Primer3 software (http://
frodo.wi.mit.edu/). All primer sequences used in this study are shown in 
Supplementary Table 5.
Computational analyses of RNA-seq data. RNA-seq reads were trimmed 
with TrimGalore (v0.4.0; http://www.bioinformatics.babraham.ac.uk/projects/
trim_galore/) and mapped to Ensembl annotation release 78 with TopHat2 
(v2.0.13; ref. 50) with the options mate-inner-dist, mate-std-dev and library-type 
(fr-firststrand). The distances between read mates (mate-inner-dist and mate-
std-dev) were assessed individually with RSeQC (v2.6.1; ref. 51). After mapping 
of the RNA-seq reads from all samples to the mouse genome build mm10, the 
reads that mapped uniquely to the genome were counted with featureCounts52 
with the following options: --Q 10 --p --B --C --s 2. The annotations present in 
the Mus musculus gtf file from Ensembl release 78 were used as a reference for 
counting. DESeq2 (ref. 53) was used for differential expression analysis. Genes 
with an adjusted P value <0.01 were defined as significantly affected. Raw reads 
were downloaded from publicly available RNA-seq data (Kap1, GSE74278; Setdb1 
and Dnmt, GSE29413) and processed as described above.
In addition, RNA-seq reads from ESCs, NPCs and macrophages were ana-
lyzed in an allele-specific manner through methodology described in a recent 
study54. Briefly, two pseudogenomes were generated for both parental geno-
types with known SNPs and indels from the Mouse Genomes Project (down-
loaded from ftp://ftp-mouse.sanger.ac.uk/REL-1410-SNPs_Indels/). Reads were 
mapped to maternal and paternal pseudogenomes. Both alignments were then 
merged to define the origin of a read (maternal genome, paternal genome or 
indistinguishable). Allele-specific expression changes were calculated with a 
generalized linear model within DESeq2 (ref. 53).
Allele-specific expression was correlated with known polymorphic ERVs with 
data from a recent study13. Only ERVs that were present and annotated in the 
reference strain (C57Bl6), were considered. ERVs present in 129S1 or CASTEiJ, 
but not in the reference C57Bl6 strain, had no subclassification (such as IAPEz, 
MERV-L) and therefore could not be used for the analysis. Of the ERV instances 
present in only one of the two parental strains (129S1 and CASTEiJ), we used 
those belonging either to MERV-L or IAPEz. ERV-gene pairs were then short-
listed only if the gene had at least one SNP in its exonic region to distinguish the 
two alleles. Because we were interested in ERV insertions responsible for inducing 
expression of nearby genes, we filtered out all genes that did not exhibit signifi-
cantly changed allele-specific expression patterns. Additionally, we observed that 
genes that were induced after HSP90i were more weakly expressed than genes 
that remained unchanged or were downregulated after inhibition. Therefore, we 
removed the top 25% highly expressed genes.
For tissue-specific gene-expression plots, RPKM values from ENCODE data 
(http://promoter.bx.psu.edu/ENCODE/downloads/mm65.long.gene.with.expr.
cshl.tsv) were clustered and visualized with the ‘pheatmap’ package55.
Analysis of repetitive elements. RNA-seq reads were mapped to the mouse 
genome assembly mm10 with Bowtie2 (ref. 56) with random assignment of 
multimapping reads. Reads with more than three mismatches were discarded. 
RepeatMasker annotations (downloaded from the UCSC genome browser on 
28 July 2015) were used as input for the bamCoverage subcommand of the 
BEDtools suite57 to count repetitive-element reads with the --split option. 
Differential expression was analyzed with DESeq2 (ref. 53).
To investigate the factor mimicking the effect of HSP90 inhibition, we used 
publicly available RNA-seq data sets in the presence or absence of known ERV 
repressors. Raw reads were downloaded from publicly available RNA-seq data 
(EED, GSE51006; DNMT, GSE29413; SUV39h, GSE57092; HDAC, GSE45909; 
HP1, GSE47370; G9a, GSE46545 and GSE36896; Kap1, GSE41903; Setdb1, 
GSE29413; and TET, GSE56986) (refs. 30–38) and processed as described above. 
Hierarchical clustering was limited to ERV elements that were upregulated after 
HSP90 inhibition with at least 100 reads. Visualization was done with the pheat-
map function available in the pheatmap55 R package with the Euclidean distance 
metric and ward agglomeration method.
Neighborhood analysis. To analyze the expression changes of genes in the 
flanking regions of ERVs, we merged elements of the same type within 400 bp. 
The 100-kb flanking regions on both sides were then binned with the flank and 
window subcommands in the BEDtools suite57. Genes overlapping those bins 
were identified with the intersectBed subcommand. Custom scripts were used 
to combine all genes within the same bin of each type of ERV element. Within 
each bin, a gene was considered only once. All genes, for which a log2 fold 
change could not be determined by DESeq2 (ref. 53), owing to numerical 
problems, were removed from the analysis. Calculation and plotting of the 
mean log2 fold change of all genes per bin was done with a custom R script 
with the ggplot2 package58.
To further define the neighborhood effect, we next considered only the closest 
up- and downstream gene with the closestBed subcommand of the BEDtools 
suite57. Again, only genes for which a log2 fold change could be determined by 
DESeq2 were considered. Genes adjacent to more than one ERV (IAPEz, MERV-
L or ORR1D2) were removed from the analysis to decrease compound effects. 
We performed two-sided Wilcoxon tests to investigate whether genes closer to 
certain ERV elements, as compared with all genes, showed a higher upregulation 
on average after HSP90 inhibition.
For plot design, we applied a random subsampling approach. To obtain a dis-
tribution of log2 fold changes that could be expected by chance, we subsampled 
the set of all genes with at least one RNA-seq read count with a sample size of 100 
and calculated the mean log2 fold change for each subset of genes (total number 
of considered annotated transcribed regions: 21,753 (ESC); 18,212 (NPCs) and 
17,294 (macrophages)). This step was repeated 10,000 times. To compare the log2 
fold changes of all genes with those of the genes closest to ERVs (Supplementary 
Fig. 2b), the same subsampling approach was also applied to the set of closest up- 
and downstream genes for each ERV instance in the genome. Both distributions 
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ChIP–seq and ChIP–qPCR analysis. For publicly available data, raw reads were 
downloaded for H3K9me3 (GSE41903) and KAP1 (GSE58323) ChIP–seq experi-
ments and trimmed with TrimGalore (v0.4.0; http://www.bioinformatics.babra-
ham.ac.uk/projects/trim_galore/). Mapping was done with Bowtie2 with default 
parameters and mouse genome build mm10. Bigwig files and profile plots were 
generated with the bamCoverage, computeMatrix and plotProfile modules of the 
deepTools package59. Peaks were called by using MACS2 (ref. 60).
KAP1 and H3K9me3 ChIP were performed under standard conditions as 
previously described61, with anti-KAP1 (Abcam, ab22553) and anti-H3K9me3 
(a kind gift from T. Jenuwein)31. HSP90 ChIP was performed on ESCs express-
ing biotin-tagged HSP90 that were generated as previously described62, with a 
modified chromatin preparation protocol from ref. 61. ChIP DNA was puri-
fied with phenol–chloroform extraction and ethanol precipitation and used for 
ChIP–qPCR. Enrichment of the immunoprecipitated DNA at the corresponding 
loci was expressed as a percentage relative to the input DNA.
Pulldown, knockdown and knockout experiments. HSP90 and KAP1 com-
plexes were purified from ESC extracts with PU-H71 beads, as previously 
described40, or with anti-KAP1 (Abcam, ab22553), respectively. The enriched 
complexes were blotted and probed with anti-HSP90β (Abcam, ab53497) or anti-
KAP1 (Abcam, ab22553). Antibody validation is provided on the manufacturer’s 
website. Antibody validation is provided on the manufacturer’s website. HSP90 
isoforms were knocked down with shRNA as previously described63, with sug-
gestions from C. Miething (University Clinic Freiburg). Conditional knockout 
of KAP1 was generated with floxed KAP1 cells (gift from D. Trono), according 
to a previously published protocol37.
Generation and analysis of IAPEz deletion with CRISPR–Cas9. Guide RNA 
(gRNA) sequences were designed to generate a specific deletion of IAPEz upstream 
of the C1s1 gene with ‘Chopchop’ (https://chopchop.rc.fas.harvard.edu/). 
Each gRNA sequence was verified to be a unique target in the mouse genome 
with BLAT and was tested for efficiency with T7 endonuclease assays64. gRNA 
oligonucleotides were cloned into pSpCas9(BB)-2A-EGFP or pSpCas9(BB)-
2A-Puro vectors. pSpCas9(BB)-2A-GFP (PX458) and pSpCas9(BB)-2A-PURO 
(PX459) V2.0 were a gift from F. Zhang (Addgene plasmid nos. 48138 and 
62988, respectively).
Mouse ESCs grown on feeder cells were cotransfected with both gRNA 
constructs and were either FACS-sorted (EGFP) or placed under puromycin 
(1 µg/mL) selection for 3 d. Clonal cell lines were established with limiting 
dilution cloning. Clones were screened for homozygous deletions by using 
PCR with flanking primer pairs at the expected genomic deletion site (Fig. 4a). 
Deletion sequences were confirmed through direct sequencing of PCR products 
with Sanger sequencing.
Data availability. All the sequencing data generated in this study have 
been deposited in the Gene Expression Omnibus database under accession 
number GSE87119. Other data are available from the corresponding author 
after reasonable request.
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